Active Shortage Injection Anesthesia
Etomidate Injection · 1,437 days since initial FDA posting
Brand: ETOMIDATE
FDA lists Etomidate Injection as Active Shortage (Mylan Institutional, a Viatris Company).
Availability on file: Available
Etomidate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Etomidate Injection
- Manufacturer
- Mylan Institutional, a Viatris Company
- Dosage Form
- Injection
- Presentation
- Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)
- Package NDC
- 67457-902-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Oct 5, 2022
- Last Updated
- Mar 18, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Etomidate Shortage Records
Etomidate Injection
Gland Pharma Limited
Injection
Etomidate Injection
Gland Pharma Limited
Injection
Etomidate Injection
Mylan Institutional, a Viatris Company
Injection
Etomidate Injection
Hospira, Inc., a Pfizer Company
Injection
Etomidate Injection
Hospira, Inc., a Pfizer Company
Injection
Etomidate Injection
Hikma Pharmaceuticals USA, Inc.
Injection